Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
A Pilot Study of Gender Differences in the Prevalence of Undiagnosed Diabetes in Acute Coronary Syndromes (ACS)
3 other identifiers
observational
103
1 country
2
Brief Summary
The primary goal of this study is to measure the prevalence of undiagnosed pre-diabetes/diabetes among women hospitalized with acute coronary syndromes (ACS) compared to men. Inpatients with confirmed ACS (and no known prior history of diabetes) are invited to return to the Yale Hospital Research Unit 6-8 weeks after hospital discharge for an oral glucose tolerance test to identify individuals with pre-diabetes and diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2001
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 27, 2007
CompletedFirst Posted
Study publicly available on registry
January 9, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedAugust 30, 2023
August 1, 2023
3.9 years
December 27, 2007
August 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of undiagnosed pre-diabetes or undiagnosed diabetes
after hospitalization for acute coronary syndrome
Study Arms (2)
1
non-diabetic women with acute coronary syndrome (ACS)
2
non-diabetic men with acute coronary syndrome (ACS)
Eligibility Criteria
Women and men admitted with an acute coronary syndrome who do not have a prior diagnosis of diabetes
You may qualify if:
- acute coronary syndrome
- age \> 30 yrs
You may not qualify if:
- previously diagnosed diabetes
- ACS due to substance abuse or trauma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- American Heart Associationcollaborator
- Ethel F Donaghue Women's Health Investigator's Program at Yalecollaborator
Study Sites (2)
Bridgeport Hospital
Bridgeport, Connecticut, 06610, United States
Yale Center for Clinical Investigation
New Haven, Connecticut, 06520, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara I Gulanski, MD, MPH
Yale University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 27, 2007
First Posted
January 9, 2008
Study Start
October 1, 2001
Primary Completion
September 1, 2005
Study Completion
December 1, 2008
Last Updated
August 30, 2023
Record last verified: 2023-08